🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

3+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 3 of 3 recruiting trials for “Aggressive NK-cell leukemia”

Phase 2RecruitingNCT06716658 ↗

JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

🏥 Institute of Hematology & Blood Diseases Hospital, China📍 2 sites📅 Started Dec 2024View details ↗
Phase 1, PHASE2RecruitingNCT05863234 ↗

Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia

🏥 Hiroshima University Hospital📍 1 site📅 Started Sep 2023View details ↗
Phase 2RecruitingNCT05941156 ↗

Clinical Study of Anti-CD56-CAR-T in the Treatment of Relapsed/Refractory NK/T Cell Lymphoma /NK Cell Leukemia

🏥 The Affiliated Hospital of Xuzhou Medical University📍 1 site📅 Started May 2023View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →